Waldencast plc (WALD)

Market Cap	630.00M
Revenue (ttm)	201.71M
Net Income (ttm)	-124.98M
Shares Out	122.21M
EPS (ttm)	-5.71
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,650
Open	5.19
Previous Close	5.30
Day's Range	5.07 - 5.27
52-Week Range	5.00 - 12.00
Beta	n/a
Analysts	Buy
Price Target	10.00 (+96.46%)
Earnings Date	Mar 20, 2024

About WALD

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other phy...

• Industry: Software - Application
• Sector: Technology
• IPO Date: Mar 16, 2021
• Employees: 272
• Stock Exchange: NASDAQ
• Ticker Symbol: WALD

Financial Performance

In 2021, Waldencast's revenue was $142.47 million, an increase of 50.88% compared to the previous year's $94.43 million. Losses were -$19.58 million, 726.0% more than in 2020.

Analyst Forecast

According to 2 analysts, the average rating for WALD stock is "Buy." The 12-month stock price forecast is $10.0, which is an increase of 96.46% from the latest price.

Price Target

$10.0

(96.46% upside)

Analyst Consensus: Buy